Nearly 90,000 bottles of children’s liquid pain medication recalled
Key Points:
- Nearly 90,000 bottles of Taro Pharmaceuticals’ Children’s Ibuprofen Oral Suspension have been recalled due to reports of black specs and other contaminants in the product.
- The berry-flavored pain reliever, intended for children ages 2 to 11, was found to contain a gel-like mass and black particles, prompting the recall earlier this month.
- The FDA classified the recall as low risk, stating the chance of serious injury or health consequences to consumers is "remote."
- The medication was manufactured in India by Strides Pharma Inc., which initiated the recall; both Strides and Taro Pharmaceuticals have not yet commented.